Is there any additional value to 68Ga-PSMA PET/CT in patients with suspicion of prostate cancer despite negative MRI and systematic biopsy?

2020 ◽  
Vol 72 (4) ◽  
Author(s):  
Joris G. Heetman ◽  
Jules Lavalaye ◽  
Sandrine van Selm ◽  
Erik J. van der Hoeven ◽  
Harm H. van Melick ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Psma Pet ◽  
Pet Ct ◽  
Additional Value ◽  
Systematic Biopsy

Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT

2017 ◽  
Vol 28 (2) ◽  
pp. 610-619 ◽  
Author(s):  
Jan-Carlo Janssen ◽  
Sebastian Meißner ◽  
Nadine Woythal ◽  
Vikas Prasad ◽  
Winfried Brenner ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Bone Metastases ◽  
Cancer Patients ◽  
Low Dose ◽  
Low Dose Ct ◽  
Psma Pet ◽  
Pet Ct ◽  
Additional Value

Interim PSMA PET/CT Response Is Predictive of Survival of Prostate Cancer Patients Treatedwith Lu-177 PSMA DKFZ 617

2020 ◽  
Author(s):  
V Prasad ◽  
K Huang ◽  
N Czech ◽  
S Prasad ◽  
MR Makowski ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Psma Pet ◽  
Pet Ct

Molecular imaging with 64Cu-PSMA PET/CT in Theranostics of prostate cancer

2016 ◽  
Author(s):  
Aviral Singh ◽  
Harshad Kulkarni ◽  
Richard P. Baum
Keyword(s):  
Prostate Cancer ◽  
Molecular Imaging ◽  
Psma Pet ◽  
Pet Ct

Krebstherapie – 68Ga-PSMA-PET/CT beim rezidivierten Prostatakarzinom richtungweisend und kosteneffektiv

2020 ◽  
Vol 25 (04) ◽  
pp. 184-185
Author(s):  
Susanne Krome
Keyword(s):  
Prostate Cancer ◽  
Cancer Recurrence ◽  
Intention To Treat ◽  
Biochemisches Rezidiv ◽  
Choline Pet ◽  
Psma Pet ◽  
Pet Ct ◽  
Prostate Cancer Recurrence ◽  
Treat Analysis

Schwenck J et al. Intention-to-Treat Analysis of 68Ga-PSMA and 11C-Choline PET/CT Versus CT for Prostate Cancer Recurrence After Surgery. J Nucl Med 2019; 60: 1359–1365 15–40 % der Patienten mit einem Prostatakarzinom erleiden postoperativ ein biochemisches Rezidiv. In der retrospektiven Analyse beeinflussten die Bildgebungsverfahren die Häufigkeit einer richtigen Therapiewahl. Die Autoren empfehlen die 68Ga-PSMA-PET/CT, die die höchste Genauigkeit aufwies. Unter Berücksichtigung der Kosten für inadäquate Behandlungen entstünden keine ökonomischen Nachteile.

OC-0208: Comparison between 68Ga-PSMA-PET/CT and mpMRI for radiotherapy planning in primary prostate cancer

2020 ◽  
Vol 152 ◽  
pp. S104
Author(s):  
S. Spohn ◽  
C. Jaegle ◽  
A.S. Bettermann ◽  
S. Kiefer ◽  
C.A. Jilg ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radiotherapy Planning ◽  
Primary Prostate Cancer ◽  
Psma Pet ◽  
Pet Ct
Sign in / Sign up

Export Citation Format

Share Document